Skip to main content
DIAN DIAGNOSTICS GROUP CO.,LTD. logo

DIAN DIAGNOSTICS GROUP CO.,LTD. — Investor Relations & Filings

Ticker · 300244 ISIN · CNE1000015N1 LEI · 3003006MMJLCVIIKTA82 Shenzhen Stock Exchange Human health and social work activities
Open in API
Filings indexed 2,161 across all filing types
Latest filing 2024-04-19 Capital/Financing Update
Country CN China
Listing Shenzhen Stock Exchange 300244

About DIAN DIAGNOSTICS GROUP CO.,LTD.

https://www.dazd.cn

DIAN Diagnostics Group Co., Ltd. is a comprehensive medical diagnostic service provider specializing in the independent clinical laboratory (ICL) sector. The company operates through an integrated "Service + Product" business model, offering a wide range of diagnostic services including clinical testing, pathology, forensic identification, and genomic testing. It manages an extensive network of diagnostic laboratories and provides outsourced testing services to medical institutions. In addition to laboratory services, the group distributes in vitro diagnostic (IVD) instruments and reagents from global and domestic manufacturers. Its technical capabilities span molecular diagnostics, mass spectrometry, and digital pathology, supporting precision medicine and public health initiatives. The company serves hospitals, community health centers, and research institutions, focusing on enhancing diagnostic efficiency and clinical decision-making through advanced technology.

Recent filings

Filing Released Lang Actions
关于使用部分闲置自有资金进行现金管理的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from a company about the decision to use part of its idle funds for cash management, including details on the amount, purpose, risk control measures, and approvals by the board and supervisory committee. It does not contain financial statements, quarterly or annual results, or detailed financial data. It is a regulatory announcement about a financing or capital management activity, specifically about the use of idle funds for investment in low-risk financial products. This fits best under Capital/Financing Update (CAP) as it relates to the company's capital management and investment activities. The document length is short (1824 characters), but it is not merely announcing the publication of a report; it is the actual announcement of a financing decision. Therefore, the correct classification is CAP with high confidence.
2024-04-19 Chinese
独立董事2023年度述职报告（丁国其）
Board/Management Information Classification · 95% confidence The document is a detailed annual report by an independent director of the company, describing their duties, attendance at board and committee meetings, opinions on various company matters, communication with auditors, and efforts to protect investor rights during the year 2023. It is a formal report on the director's activities and responsibilities over the year, not an announcement or a brief notice. The content focuses on board and management oversight and governance activities rather than financial results or regulatory filings. Therefore, it fits best under the category of Board/Management Information (MANG), which covers announcements of changes or reports related to the company's board or senior management activities.
2024-04-19 Chinese
关于拟续聘会计师事务所的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the proposed reappointment of an accounting firm (Lixin CPA Firm) for the company's 2024 audit. It details the firm's background, qualifications, audit fees, and the approval process by the board and audit committee. There is no actual audit report or financial statements included, nor is this a full annual or interim report. The document is a formal announcement about the auditor appointment, not the audit report itself. Given the content and length (2786 characters), it fits best as a Regulatory Filing (RNS) because it is a regulatory announcement about auditor reappointment rather than an audit report or annual report.
2024-04-19 Chinese
2023年度环境、社会及公司治理（ESG）报告
Environmental & Social Information Classification · 95% confidence The document is titled "2023 迪安诊断 环境、社会及公司治理（ESG）报告" which translates to "2023 Dian Diagnostics Environmental, Social and Governance (ESG) Report." The content extensively covers ESG topics such as environmental responsibility, social responsibility, governance structure, supply chain responsibility, community engagement, and sustainability initiatives. It includes detailed sections on company governance, social responsibility, environmental management, and stakeholder communication. There is no indication that this is an annual financial report, earnings release, or any other financial filing. Instead, it is a comprehensive ESG report, which matches the description of Environmental & Social Information (Code: SR). The document length is substantial (15,000 characters), indicating it is the full report, not just an announcement or summary. Therefore, the correct classification is SR with high confidence.
2024-04-19 Chinese
关于2023年度利润分配预案的公告
Notice of Dividend Amount Classification · 95% confidence The document is an announcement regarding the 2023 annual profit distribution plan of the company, including details about dividends per share, total dividend amount, and the approval process involving the board of directors and supervisory board. It explicitly states that the plan needs to be submitted to the 2023 annual shareholders' meeting for approval. The document does not contain full financial statements or comprehensive financial performance data, but rather focuses on the dividend distribution proposal and related approvals. The document length is short (1623 characters) and it is an announcement of a profit distribution plan, which aligns with a Notice of Dividend Amount (DIV) filing type rather than a full Annual Report or Earnings Release. Therefore, the correct classification is Notice of Dividend Amount (DIV).
2024-04-19 Chinese
关于2023年度计提资产减值准备的公告
Regulatory Filings Classification · 95% confidence The document is an announcement by the company regarding the 2023 annual asset impairment provision. It details the reasons, scope, amounts, accounting standards, and approval procedures related to the asset impairment provision. The document is relatively short (3568 characters) and focuses on a specific accounting adjustment rather than presenting a full financial report or comprehensive financial statements. It does not contain full financial statements or detailed financial analysis typical of an Annual Report (10-K) or Interim Report (IR). Instead, it is a regulatory announcement about a specific accounting provision approved by the board and supervisors. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2024-04-19 Chinese

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.